Bio-Techne
TECH
#1708
Rank
HK$75.91 B
Marketcap
HK$480.22
Share price
0.85%
Change (1 day)
-17.54%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

EPS for Bio-Techne (TECH)

EPS in 2023 (TTM): HK$12.30

According to Bio-Techne's latest financial reports the company's current EPS (TTM) is HK$12.21. In 2022 the company made an earnings per share (EPS) of HK$13.01 an increase over its 2021 EPS that were of HK$10.46.

EPS history for Bio-Techne from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$12.30-5.42%
2022HK$13.0124.35%
2021HK$10.4617.98%
2020HK$8.87-10.94%
2019HK$9.95101.57%
2018HK$4.94-17.53%
2017HK$5.9939.37%
2016HK$4.30-17.23%
2015HK$5.19-14.97%
2014HK$6.101.29%
2013HK$6.033.68%
2012HK$5.81-1.97%
2011HK$5.931.67%
2010HK$5.837.14%
2009HK$5.44-1.06%
2008HK$5.5019.41%
2007HK$4.6119.1%
2006HK$3.8710.56%
2005HK$3.5029.5%
2004HK$2.7013.05%
2003HK$2.3968.43%
2002HK$1.42-17.05%
2001HK$1.7117.33%
2000HK$1.4648.51%
1999HK$0.9823.17%
1998HK$0.8013.89%
1997HK$0.7042.57%
1996HK$0.49

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
HK$119.30 877.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$44.48-464.33%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$43.16 253.50%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$62.37 410.83%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$11.31-7.38%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
HK$66.49 444.59%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$7.31-159.87%๐Ÿ‡บ๐Ÿ‡ธ USA